FOXA1 and cancer: In a real-time qPCR study on breast cancer cell lines from American type tissue culture collection, FOXA1 was reported as an independent subtyping biomarker for TNBCs identification, and halts the triple negative feature of cancer cells by suppressing SOD2 expression that helps cells bypass apoptosis and inhibiting IL6 that enables stem-like features and invasive nature of TNBC [79].